Literature DB >> 16426400

Age of first faint in patients with vasovagal syncope.

Robert S Sheldon1, Aaron G Sheldon, Stuart J Connolly, Carlos A Morillo, Thomas Klingenheben, Andrew D Krahn, Mary-Lou Koshman, Debbie Ritchie.   

Abstract

INTRODUCTION: Understanding whether vasovagal syncope is a lifelong disorder might shed insight into its physiology and affect management strategies. Accordingly, we determined the age of the first syncopal spell in adult patients who sought care for syncope. METHODS AND
RESULTS: Patients were 42 +/- 18 years old with 64% women. They had had a median 8 syncope spells (interquartile range [IQR]: 4, 20) with a median frequency of 1.0 syncopal spells per year. The range of syncopal spells was 1-3,375, and the range of duration of history of syncope was 0.003-70 years. The first syncopal spell occurred at ages 0-81 in a skewed distribution, with a marked mode age of 13 years, a median age of 18 years (IQR 12, 37), and a mean age of 26 +/- 20 years. The distributions were statistically indistinguishable across countries (P = 0.50), among Canadian regions (P = 0.69), and between the studies (P = 0.49). The same modal values were seen in males and females, and in patients <40 and > or =40 years old. However, patients > or =40 years had median ages of onset older than patients <40 years (36 +/- 23 vs 17 +/- 8 years). Patients had a recalled history of syncopal spells of median duration of 10 years (IQR: 2, 23), with a range of 0.003-70 years. An age of onset <44 years was 86% accurate for vasovagal syncope.
CONCLUSION: The most common age at which vasovagal syncope first presents is 13 years, and patients remain at risk of syncope for many years. Lifelong coping strategies may be desirable.

Entities:  

Mesh:

Year:  2006        PMID: 16426400     DOI: 10.1111/j.1540-8167.2005.00267.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  20 in total

1.  Alteration of gene expression profiling including GPR174 and GNG2 is associated with vasovagal syncope.

Authors:  Yu-Juan Huang; Zai-wei Zhou; Miao Xu; Qing-wen Ma; Jing-bin Yan; Jian-yi Wang; Quo-qin Zhang; Min Huang; Liming Bao
Journal:  Pediatr Cardiol       Date:  2014-11-01       Impact factor: 1.655

Review 2.  Current concepts in the evaluation and management of syncope.

Authors:  Vikas Kuriachan; Robert S Sheldon
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

3.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

4.  Calgary score and modified Calgary score in the differential diagnosis between neurally mediated syncope and epilepsy in children.

Authors:  Runmei Zou; Shuo Wang; Liping Zhu; Lijia Wu; Ping Lin; Fang Li; Zhenwu Xie; Xiaohong Li; Cheng Wang
Journal:  Neurol Sci       Date:  2016-10-17       Impact factor: 3.307

Review 5.  Typical vasovagal syncope as a "defense mechanism" for the heart by contrasting sympathetic overactivity.

Authors:  Paolo Alboni; Marco Alboni
Journal:  Clin Auton Res       Date:  2017-07-01       Impact factor: 4.435

6.  Gender difference in patients with recurrent neurally mediated syncope.

Authors:  Jungwae Park; Shin Yi Jang; Hye Ran Yim; Young Keun On; June Huh; Dae-Hee Shin; Jun Hyung Kim; June Soo Kim
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

7.  Management of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia and Vasovagal Syncope.

Authors:  Satish Raj; Robert Sheldon
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 8.  Postural tachycardia syndrome and reflex syncope: similarities and differences.

Authors:  Julian M Stewart
Journal:  J Pediatr       Date:  2009-04       Impact factor: 4.406

Review 9.  Vasovagal Syncope As A Manifestation Of An Evolutionary Selected Trait.

Authors:  Paolo Alboni; Marco Alboni
Journal:  J Atr Fibrillation       Date:  2014-08-31

10.  Recurrent syncope is not an independent risk predictor for future syncopal events or adverse outcomes.

Authors:  Anna Marie Chang; Judd E Hollander; Erica Su; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Bret A Nicks; Daniel K Nishijima; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun
Journal:  Am J Emerg Med       Date:  2018-08-24       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.